Efficacy of Ozoralizumab vs. Golimumab for Rheumatoid Arthritis: A Systematic Review

Efficacy of Ozoralizumab vs. Golimumab for Rheumatoid Arthritis: A Systematic Review

Introduction: Rheumatoid arthritis, a systemic autoimmune disease, affects 13% of the world population. As a well-established therapy, golimumab provides a key benchmark for assessing novel biological treatments. In contrast, ozoralizumab represents an innovative therapeutic approach. This study aim...

Full description

Saved in:

Bibliographic Details
Main Authors:	Nathania Elma Fithriyah, Khafiyah Hikmah Rahmadhani, Luthfiana Rofhani Susanti, Arifa Mustika, Lita Diah Rahmawati, Citrawati Dyah Kencono Wungu
Format:	Article
Language:	English
Published:	Faculty of Medicine, Universitas Airlangga 2025-07-01
Series:	Current Internal Medicine Research and Practice Surabaya Journal
Subjects:	ozoralizumab golimumab rheumatoid arthritis disease activity score-28 (das28) disease-modifying antirheumatic drugs (dmards)
Online Access:	https://e-journal.unair.ac.id/CIMRJ/article/view/66406
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The tumor necrosis factor-α inhibitor golimumab in the treatment of rheumatoid arthritis
by: Natalia Vladimirovna Chichasova
Published: (2014-12-01)

Effect of Ozoralizumab Administration with or without Methotrexate in Patients with Rheumatoid Arthritis: A Post-Hoc Analysis
by: Yoshiya Tanaka, et al.
Published: (2025-01-01)

GOLIMUMAB — A NEW TNF α-BLOCKER. THE REVIEW OF THE EFFICACY AND SAFETY EVALUATION RESULTS
by: R. V. Denisova, et al.
Published: (2012-07-01)

Potential therapeutic effects of IL28RA inhibition on acute myocardial infarction through phosphorylated JAK1/STAT1 signaling pathways
by: Ge Gong, et al.
Published: (2024-12-01)

Golimumab in the treatment of psoriatic arthritis: efficacy and safety
by: Tatiana Viktorovna Korotaeva, et al.
Published: (2015-09-01)

A Rare Hypersensitivity Reaction with Golimumab: Recurrent Fever After Each Injection
by: Berna Günay, et al.
Published: (2025-08-01)

Efficacy of golimumab in treating uveitis in patients with ankylosing spondylitis
by: T. V. Dubinina, et al.
Published: (2016-09-01)

Adherence to treatment with adalimumab, golimumab and ustekinumab in patients with inflammatory bowel disease
by: María Calvo-Arbeloa, et al.
Published: (2020-03-01)

Efficacy of golimumab in the treatment of patients with ankylosing spondylitis (according to the data of a long-term follow-up)
by: A. V. Smirnov, et al.
Published: (2015-03-01)

Time course of changes in the clinical and instrumental manifestations of coxitis in patients with ankylosing spondylitis during golimumab therapy: a GO-COX study. Preliminary results
by: Sh. Erdes, et al.
Published: (2019-07-01)

Long-term results of golimumab therapy for rheumatoid arthritis. Therapy compliance issues
by: N. V. Chichasova
Published: (2016-06-01)

Golimumab in the treatment of extra-skeletal manifestations of ankylosing spondylitis
by: A. B. Demina
Published: (2019-10-01)

EFFECT OF GOLIMUMAB ON IMMUNOLOGICAL MARKERS FOR BONE METABOLISM AND ON ARTERIAL STIFFNESS IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: L. A. Knyazeva, et al.
Published: (2018-07-01)

ASSESSMENT OF RHEUMATOID ARTHRITIS ACTIVITY DURING PREGNANCY AND POSTPARTUM
by: E. V. Matyanova, et al.
Published: (2015-04-01)

THE EFFECT OF GOLIMUMAB ON ARTERIAL STIFFNESS IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: L. A. Knyazeva, et al.
Published: (2018-03-01)

Golimumab in the treatment of inflammatory diseases: A role of immunogenicity
by: D. E. Karateev
Published: (2016-01-01)

Nota Editorial, Nº 28 (mayo de 2025)
by: Iñaki Rivera Beiras
Published: (2025-05-01)

Patient access to reimbursed biological disease-modifying antirheumatic drugs in the European region
by: Zoltán Kaló, et al.
Published: (2017-01-01)

Effect of golimumab on endothelial vasomotor function and arterial stiffness in ankylosing spondylitis
by: L. A. Knyazeva, et al.
Published: (2019-07-01)

Experience with tocilizumab in patients with rheumatoid arthritis (according to the data of the LORNET multicenter trial)
by: E Yu Panasyuk, et al.
Published: (2013-04-01)

Evaluation of the clinical efficiency of tocilizumab therapy, by using DAS 28, SDAI, CDAI indices and new 2011 EULAR/ACR remission criteria in patients with rheumatoid arthritis
by: Anastasia Sergeyevna Avdeyeva, et al.
Published: (2012-04-01)

Evaluation of the clinical efficiency of tocilizumab versus rituximab therapy in patients with rheumatoid arthritis
by: Anastasia Sergeyevna Avdeyeva, et al.
Published: (2012-08-01)

Not Just PA28γ: What We Know About the Role of PA28αβ in Carcinogenesis
by: Paolo Cascio
Published: (2025-06-01)

Erythropoietin as a critical prognostic indicator in ICU patients with sepsis: a prospective observational study
by: Qianping Zhang, et al.
Published: (2025-03-01)

Golimumab for Treating Chronic Inflammatory Joint Diseases in the Adult Population: Clinical Efficacy and Tolerability
by: Natal’ya N. Chichasova
Published: (2019-01-01)

Role of Cathepsin G in Rheumatoid Arthritis Diagnosis and Disease Activity Evaluation
by: Mays Saleh Khamees, et al.
Published: (2024-06-01)

Successful adalimumab graded challenge after allergic delayed reaction to golimumab in a woman with rheumatoid arthritis
by: Federica Rivolta, et al.
Published: (2023-03-01)

Serum leptin level in rheumatoid arthritis and its relationship with disease activity
by: Zena M Al-Youzbaky, et al.
Published: (2023-02-01)

Intelligent policy framework: Natural resource conservation, knowledge and big data analytics
by: Nina Xiao, et al.
Published: (2025-03-01)

LncRNA HOTAIR promotes aerobic glycolysis by recruiting Lin28 to induce inflammation and apoptosis in acute lung injury
by: Junjie Xie, et al.
Published: (2025-12-01)

Carta a los lectores
by: Mary-Luz Alzate-Zuluaga
Published: (2025-07-01)

Assessment of the banking sector's exposure to hydrometeorological events in Costa Rica
by: Irene Alvarado-Quesada, et al.
Published: (2025-09-01)

IL-28B genotypes as predictors of long-term outcome in patients with hepatitis C-related severe liver injury
by: Jelena Jordovic, et al.
Published: (2019-05-01)

Impact of interleukin 28B rs12979860 C/T polymorphism on severity of disease and response to treatment in hepatitis delta
by: Murat Ispiroglu, et al.
Published: (2017-01-01)

Medium-term economic impacts of cover crop adoption in Maryland
by: Yifei Zhang, et al.
Published: (2024-12-01)

Research on the industry sequence for the expansion of China's carbon market: From the perspectives of stabilizing economic growth and employment
by: Wen Zhou
Published: (2024-12-01)

Effects of ethical leadership on individual learning and unlearning: Mediation through affective commitment
by: Muhammad Aamir Shafique Khan, et al.
Published: (2024-09-01)

Metformin blocks BIK1-mediated CPK28 phosphorylation and enhances plant immunity
by: Yazhou Bao, et al.
Published: (2025-02-01)

Fiscal policy and deforestation
by: Luccas Assis Attílio, et al.
Published: (2024-12-01)

Complications of invasive oral procedures in patients with immune-mediated inflammatory disorders treated with biological and conventional disease-modifying antirheumatic drugs or glucocorticoids: a scoping review of the literature
by: Loredana Radoi, et al.
Published: (2025-03-01)